Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems
- PMID: 31971627
- DOI: 10.1002/bjs.11408
Modified staging system for gastric neuroendocrine carcinoma based on American Joint Committee on Cancer and European Neuroendocrine Tumor Society systems
Abstract
Background: The prognostic values of the AJCC staging system for gastric cancer (GC-AJCC), the AJCC staging system for gastric neuroendocrine tumours (NET-AJCC) and the European Neuroendocrine Tumor Society (ENETS) system for gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma (MA)NEC remain controversial.
Methods: Data on patients with (MA)NEC from 21 centres in China were analysed. Different staging systems were evaluated by performing Kaplan-Meier survival analysis and calculating the concordance index (C-index) and Akaike information criterion (AIC). Based on three existing systems, a modified staging system (mTNM) was developed.
Results: A total of 871 patients were included. In the GC-AJCC system, an overlap was noticed for pT2 and pT3 categories. Patients with stage IIIC disease had a similar prognosis to those with stage IV disease. The pT categories of the NET-AJCC system had a lower C-index and higher AIC than those of the other systems. In the ENETS system, there was a low proportion (0·2 per cent) of patients with stage IIIA and a high proportion (67·6 per cent) of stage IIIB disease. The mTNM system adopted the NET-AJCC pT and GC-AJCC pN and pM definitions, and was developed based on the ENETS stage definitions. The proportion of patients in each stage was better distributed and the mTNM system showed improved prognostic performance in predicting overall and disease-free survival.
Conclusion: The mTNM system offers more accurate prognostic value for gastric (MA)NEC than the AJCC or ENETS staging systems.
© 2020 BJS Society Ltd Published by John Wiley & Sons Ltd.
References
-
- Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717-1751.
-
- Plöckinger U, Rindi G, Arnold R, Eriksson B, Krenning EP, de Herder WW et al.; European Neuroendocrine Tumour Society. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS). Neuroendocrinology 2004; 80: 394-424.
-
- Rindi G, Klöppel G, Alhman H, Caplin M, Couvelard A, de Herder WW et al.; all other Frascati Consensus Conference participants; European Neuroendocrine Tumor Society (ENETS). TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
-
- Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 2007; 451(Suppl 1): S9-S27.
-
- Fléjou JF. WHO Classification of digestive tumors: the fourth edition. Ann Pathol 2011; 31(Suppl): S27-S31.
Publication types
MeSH terms
Grants and funding
- [2017]171/construction Project of Fujian Province Minimally Invasive Medical Center/International
- 2015J01464/Joint Health Programs of the Provincial Natural Foundation/International
- 2016QH025/QIHANG funds of Fujian Medical University/International
- 2016Y9031/the Scientific and technological innovation joint capital projects of Fujian Province/International
- 2016B013/the second batch of special support funds for Fujian Province innovation and entrepreneurship talents/International
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
